Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
Patents for C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780)
10/2005
10/13/2005WO2005094833A1 Novel n-substituted dihydrobenzothiepino, dihydrobenzoxepino and tetrahydro benzocyclohepta indoles as selective estrogen receptor modulators
10/13/2005WO2005094818A1 Azabicyclo-octane inhibitors of iap
10/13/2005WO2005094816A1 Indol-1-yl-acetic acid derivatives
10/13/2005WO2005094810A2 Novel pharmaceutical compositions
10/13/2005WO2005094805A1 Imine derivative and amide derivative
10/13/2005WO2005094323A2 Process for preparing a dipeptidyl peptidase iv inhibitor and intermediates employed therein
10/13/2005US20050228184 Beta-agonist compounds comprising nitric oxide donor groups and reactive oxygen species scavenger groups and their use in the treatment of respiratory disorders
10/13/2005US20050228180 Alpha, omega-dicarboximide derivatives as useful uro-selective a1a adrenoceptor blockers
10/13/2005US20050228137 Molded articles comprising a polycarbonate; lower color, e.g., a low yellowness index; physical properties
10/13/2005US20050228036 3-(arylamino)methylene-1,3-dihydro-2H-indol-2-ones as kinase inhibitors
10/13/2005US20050228029 sulfonylurea derivatives, sulfonylthiourea derivatives, sulfonylguanidine derivatives, sulfonylcyanoguanidine derivatives, thioacylsulfonamide derivatives, and acylsulfonamide derivatives; effective for prevention and treatment of cardiovascular diseases, particularly those diseases related to thrombosis
10/13/2005US20050228025 Substituted oxindole derivatives as tyrosine kinase inhibitors
10/13/2005US20050228021 Adamantylglycine-based inhibitors of dipeptidyl peptidase IV and methods
10/13/2005US20050228000 of the coagulation cascade or contact activation system: thrombin, factor Xa, factor XIa, factor IXa, factor VIIa or plasma kallikrein; e.g. -(6-carbamimidoyl-1H-indol-3-ylmethyl)-4-methoxy-biphenyl-2-carboxylic acid; anticoagulant, antiinflammatory agent
10/13/2005US20050227987 11beta-hydroxysteroid dehydrogenase inhibitors
10/13/2005US20050227986 Vanilloid receptor ligands and their use in treatments
10/13/2005US20050227965 Crystalline polymorph of bazedoxifene acetate
10/13/2005US20050227964 Bazedoxifene ascorbate
10/13/2005US20050227960 N-[(octahydrocyclopenta[c] pyrrol-5-ylcarbamoyl)methyl]-3 -trifluoromethylbenzamide trifluoroacetic acid salt; monocyte chemotactic proteins (MCP-1) receptor antagonist or partial agonists; antiinflammatory agent, antiallergen, autoimmune diseases; rheumatoid arthritis, atherosclerosis, asthma
10/13/2005US20050227113 Blue phosphorescence
10/13/2005US20050227076 used for immobilization of amine-containing materials such as amino acid, peptide, protein, enzyme, immunoglobulin, DNA, RNA or fragments to substrate surfaces
10/13/2005US20050226815 cyanine dyes with carboxylic acid or an aryl group; for tumor imaging or angiography; excellent in permeability in a living tissue; enables specific imaging of tumor and/or blood vessel
10/13/2005US20050225235 Materials for injecting or transporting holes and organic electroluminescence devices using the same
10/13/2005DE10393799T5 Kinaseinhibitoren für die Behandlung von Erkrankungen Kinase inhibitors for the treatment of diseases
10/13/2005DE102004014909A1 Verfahren zur Herstellung von 5-Brom-3,3-dimethyl-2,3-dihydro-1H-indol, Hydrochlorid Process for the preparation of 5-bromo-3,3-dimethyl-2,3-dihydro-1H-indole, hydrochloride
10/13/2005CA2562700A1 Novel pharmaceutical compositions
10/13/2005CA2561733A1 Pegylated ion channel modulating compounds
10/13/2005CA2558615A1 Azabicyclo-octane inhibitors of iap
10/12/2005EP1584987A2 Poly(hydrazone)-based charge transport materials
10/12/2005EP1584985A2 Hydrazone-based charge transport materials
10/12/2005EP1583972A2 Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions
10/12/2005EP1583745A1 1-propanol and 1-propylamine derivatives and their use as glucocorticoid ligands
10/12/2005EP1583743A1 Indole-phenylsulfonamide derivatives used as ppar-delta activating compounds
10/12/2005EP1583726A2 Activity-based probes, and methods of their preparation and use
10/12/2005EP1385837B1 Tricyclic alkylhydroxamates, their preparation and their use as cell proliferation inhibitors
10/12/2005EP1202964B1 Condensed indoline derivatives and their use as 5ht, in particular 5ht2c, receptor ligands
10/12/2005EP1163219B1 Substituted 1-oxo- and 1,3-dioxoisoindolines and their use in pharmaceutical compositions for reducing inflammatory cytokine levels
10/12/2005EP0999834B1 Antithrombotic agents
10/12/2005EP0946170B1 Diclofenac for the treatment of vasculopathies
10/12/2005CN1681784A Azabicyclo derivatives as muscarinic receptor antagonists
10/12/2005CN1681783A 2, 4-substituted indoles and their use as 5-HT6 modulators
10/12/2005CN1681782A 2, 7-substituted indoles and their use as 5-HT6 modulators
10/12/2005CN1681781A 新的二氢吲哚化合物和其医药用途 New indoline compound and pharmaceutical use
10/12/2005CN1681763A Chemical compounds
10/12/2005CN1681490A Melanin extinguisher
10/12/2005CN1681364A Organic electroluminescence device
10/12/2005CN1680381A Preparation of S-tricyctic lactone
10/12/2005CN1680375A Bisphenols monomer with imide structure and its synthesis
10/12/2005CN1680369A Double ketole colorless benzofuryl ketone compound and its preparation
10/12/2005CN1680338A Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds
10/12/2005CN1680323A 3-hydroxyphthalimidine derivative and synthesis thereof
10/12/2005CN1680322A Synthesis of 3-hydroxyphthalimidine derivative
10/12/2005CN1680321A Preparation of miglitol
10/12/2005CN1680320A Beta, beta-double indolene compound, synthesis and use thereof
10/12/2005CN1680319A a-methyl-beta,-beta-double indolene compound, synthesis and use thereof
10/12/2005CN1680318A Indoline derivative and method for producing the same
10/12/2005CN1680317A Indoline derivative and process for producing the same
10/12/2005CN1680298A Material and intermediate for trifluoromethyl-substituted spirocyclic ketoenols
10/12/2005CN1680294A Processes for preparation of bicyclic compounds and intermediates therefor
10/12/2005CN1680274A Substituted benzene compounds, process for their preparation, and herbicidal and defoliant compositions containing them
10/12/2005CN1680272A C2-phenyl-substituted cyclic keto-enols used as pesticides and herbicides
10/12/2005CN1222511C I-aryl-or-I-alkylsulfonyl-heterocyclylbenzazoles as 5-hydroxytryptamine-b ligands
10/12/2005CN1222291C Novel uses of combined 5-HT 1A agonists and serotonin reuptake inhibitor
10/12/2005CN1222213C Active ingredient combinations comprising insecticidal and acaricidal properties
10/11/2005US6953858 A phenylalkyl secondary- and tertiary-amides enzyme inhibitors as viricides, for treating AIDS
10/11/2005US6953812 Carboxy and amide containing compound suitable for treatment and/or prevention of diseases wherein a glucagon antagonistic action is beneficial, such as hyperglycemia, diabetes, disorders of the lipid metabolism, such as dyslipidemia
10/11/2005US6953809 Monocyte chemoattractant protein-1 inhibitor compounds
10/11/2005US6953801 Melanin concentrating hormone receptor ligands: substituted 1-benzyl-4-aryl piperazine analogues
10/11/2005US6953789 a 3- or 4-Mercapto-1-(4-phenoxybenzyl)azepine-2-one; thioetherification with a mercaptan; matrix metalloprotease (MMP) inhibitors; antiarthritic, anticaries agent;
10/06/2005WO2005094133A1 Arylamine compound and organic electroluminescent device
10/06/2005WO2005092899A1 Inhibitors of histone deacetylase
10/06/2005WO2005092897A2 2,4,6-phenylsubstituted cyclic ketoenoles
10/06/2005WO2005092857A1 Carbazole derivative containing fluorene group and organic electroluminescent element
10/06/2005WO2005092856A1 Tetrahydrocarbazoles and derivatives
10/06/2005WO2005092855A1 Process for cross coupling indoles
10/06/2005WO2005092854A1 Bicyclic substituted indole-derivative steroid hormone nuclear receptor modulators
10/06/2005WO2005092853A1 Method for producing 5-bromo-3,3-dimethyl-2,3-dihydro-1h-indole hydrochloride
10/06/2005WO2005092841A1 Compounds having beta-agonist activity
10/06/2005WO2005092840A1 Formamide derivatives useful as adrenoceptor
10/06/2005WO2005092305A2 Compounds for treating aids and other diseases
10/06/2005WO2005074387A3 Novel crystal forms of 4-[2-di-n-propylamino)ethyl]-2 (3h)- indolone hydrochloride
10/06/2005WO2005066135A3 Pyrrole and pyrazole daao inhibitors
10/06/2005US20050222428 For preparation of chiral cycloalkanoindole prostaglandin (DP) receptor antagonists in high enantiomeric excess
10/06/2005US20050222423 Carboxylic acid derivative
10/06/2005US20050222255 Process for producing trans-4-amino-1-cyclohexanecarboxilic acid derivative
10/06/2005US20050222243 Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use
10/06/2005US20050222242 Process for preparing a dipeptidyl peptidase IV inhibitor and intermediates employed therein
10/06/2005US20050222216 Carboxyoic acid compounds and drugs containing the compounds as the active ingredient
10/06/2005US20050222201 such as 3-(2-chloro-4-quinolinyl)-2,5-dimethyl-1H-indole-1-acetic acid, used for treating respiratory system disorders and as inhibitors of G protein-coupled receptor chemoattractant homologous receptor expressed on lymphocyte cells (CRTH2)
10/06/2005US20050222200 4-(2,2-dichloro)-N-(quinolin-3-yl)benzamide; (1R,2R)2-methyl-N-(quinolin-3-yl)-4-(2-(trifluoromethyl)cyclopropyl)benzamide; inflammation-related conditions in mammals, arthritis, Parkinson's/Alzheimer's diseases, stroke, asthma; acute/chronic or neuropathic pain; VR1 agonist/antagonist
10/06/2005US20050222148 Phenylaminopropanol derivatives and methods of their use
10/06/2005US20050222146 N-substituted-n-sulfonylaminocyclopropane compounds and pharmaceutical use thereof
10/06/2005US20050222126 Antiangiogenic compounds and an assay for inhibitors of cell invasion
10/06/2005US20050222124 Benzenesulfonamide derivatives as antipsychotic agents
10/06/2005US20050222047 Compounds as enzyme inhibitors to treat hepatitis with viricides
10/06/2005US20050221213 Hydrazone-based charge transport materials
10/06/2005US20050221212 Photoconductive element includes a charge generating compound and a charge transport material that is a polyether, a polyamine or a polythioether with pendant hydrazone groups, e.g., the reaction product of 9-(2,3-epoxypropyl)-3-formylcarbazole and N-methyl-N-phenylhydrazone
10/06/2005US20050221124 Fluorene-based compound and organic electroluminescent display device using the same
10/06/2005DE102004014620A1 2,4,6-phenylsubstituierte cyclische Ketoenole 2,4,6-substituted cyclic ketoenols
10/06/2005CA2561076A1 2,4,6-phenylsubstituted cyclic ketoenoles
1 ... 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 ... 458